Last reviewed · How we verify
4-day Plaque Accumulation Model Evaluating Compound Containing Gum
This will be a single-blind, single-center, 3-way crossover, randomized controlled clinical trial with 3 treatment periods utilizing 32 subjects. (Fig 1, in protocol) Each treatment period will be 4 days (96 hours +/-3 hours) in accordance with the plaque accumulation model using one of the following treatment groups: an active compound MIIP-E2 gum (experimental regimen), an inactive compound gum (negative control regimen), and a no-gum (control regimen).
Details
| Lead sponsor | Lactea Therapeutics, LLC |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 32 |
| Start date | Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Feb 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Dental Plaque Accumulation
Interventions
- MIIP-E2 containing gum
- placebo gum without MIIP-E2
Countries
United States